Bausch + Lomb Corporation Stock Analysis & AI Score
Bausch + Lomb Corporation (BLCO) has an ST Score of 52.6 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D). Analysts rate it Buy with a $20.20 price target (+20.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Bausch + Lomb Corporation (BLCO) has an ST Score of 52.6 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D). Analysts rate it Buy with a $20.20 price target (+20.2% upside).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthD
All factor grades
- SentimentA+
- ValuationB+
- GrowthB
- ForecastB-
- MomentumC+
- ProfitabilityD+
- Financial StrengthD
- Piotroski4/9
Contact
BLCO stock: frequently asked questions
What is BLCO's ST Score?
Bausch + Lomb Corporation (BLCO) has an ST Score of 52.6 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BLCO a buy, hold, or sell?
Analysts rate BLCO a Buy, with a price target of $20.20 (+20.2% vs the current price). Our ST Score grades it B- (52.6/100). The ST Score is a data-driven signal, not a recommendation.
What are BLCO's factor grades?
Valuation B+, Profitability D+, Financial Strength D, Momentum C+, Growth B, Forecast B-, Sentiment A+.
What is BLCO's valuation grade?
Bausch + Lomb Corporation (BLCO) earns a valuation grade of B+, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BLCO's growth grade?
Bausch + Lomb Corporation (BLCO) earns a growth grade of B, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BLCO's profitability grade?
Bausch + Lomb Corporation (BLCO) earns a profitability grade of D+, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BLCO's financial strength grade?
Bausch + Lomb Corporation (BLCO) earns a financial strength grade of D, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BLCO?
The average analyst price target for Bausch + Lomb Corporation (BLCO) is $20.20 from 17 analysts, which is +20.2% versus the recent price of $16.80.
What is BLCO's Piotroski score?
Bausch + Lomb Corporation (BLCO) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.